First-in-Human Trial to Enroll 24 Patients with Refractory Solid Tumors
MOUNTAIN VIEW, Calif., Dec. 21, 2020 /PRNewswire/ — BioEclipse Therapeutics™ (BioEclipse), a private clinical-stage biopharmaceutical company with a proprietary platform for dev… […]
SAN DIEGO, Dec. 18, 2020 /PRNewswire/ — BioAtla, Inc. (Nasdaq: BCAB), a clinical-stage biopharmaceutical company developing a novel class of highly specific and selective antibody-based therapeutics for the treatment of solid tumor cancer, today an… […]
CARLSBAD, Calif., Dec. 18, 2020 /PRNewswire/ — Qualigen Therapeutics, Inc. (Nasdaq: QLGN) today announced the closing of its previously announced registered direct offering with a single institutional investor for the purchase and sale for $12,000,… […]
Biotech startup has developed a new genetic coding process to synthesize proteins and peptide hormones; rBIO’s platform for synthetic insulin achieves success as the team looks to production scale-up and a range of other prescription drugs to target
… […]
NOVATO, Calif., Dec. 16, 2020 /PRNewswire/ — The Buck Institute for Research on Aging is pleased to announce the appointment of Malene Hansen PhD to the position of Professor and Chief Scientific Officer. She will begin her transition to the Buck o… […]
SAN MATEO, Calif., Dec. 16, 2020 /PRNewswire/ — Vivace Therapeutics, Inc., a small molecule discovery and development company developing first-in-class therapies targeting the Hippo pathway, announced today the closing of a $30 million Series C fin… […]
SAN DIEGO, Dec. 15, 2020 /PRNewswire/ — BioAtla, Inc. (Nasdaq: BCAB), a clinical-stage biopharmaceutical company developing a novel class of highly specific and selective antibody-based therapeutics for the treatment of solid tumor cancer, today an… […]
CARLSBAD, Calif., Dec. 15, 2020 /PRNewswire/ — Qualigen Therapeutics, Inc. (Nasdaq: QLGN), a biotechnology company focused on developing novel therapeutics for the treatment of cancer and infectious diseases, today announced that the United States … […]
SAN DIEGO and SHANGHAI, Dec. 15, 2020 /PRNewswire/ — Singlera Genomics Inc. today announced that it raised $150 million in Series B financing. This round of financing was led by the CICC Kai Tak Innovative Biomedicine Fund, and co-led by Detong Cap… […]
Turnkey research facility expands network in biotech-rich area
SAN DIEGO, Dec. 15, 2020 /PRNewswire/ — Explora BioLabs, a national provider of best-in-class vivarium research space and management services based here, will launch three new facilities… […]
Copyright © 2021 | MH Magazine WordPress Theme by MH Themes
